Cerevel Therapeutics Holdings Inc (CERE) Insider Trading
- $206,869,943.27
- $44,713,623.00
- July 1, 2024
- N Anthony Coles
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 1, 2024 | Director | 25,000 | $41.18 | Sell | $1,029,500.00 | |
May 10, 2024 | Director | 50,000 | $42.10 | Sell | $2,105,000.00 | |
March 4, 2024 | Director | 50,000 | $41.01 | Sell | $2,050,500.00 | |
Feb. 29, 2024 | Director | 50,000 | $41.16 | Sell | $2,058,000.00 | |
Feb. 7, 2024 | Director | 2,506 | $41.54 | Sell | $104,099.24 | |
Feb. 7, 2024 | Insider | 2,161 | $41.54 | Sell | $89,767.94 | |
Dec. 26, 2023 | Insider | 10,000 | $42.47 | Sell | $424,700.00 | |
Dec. 22, 2023 | Insider | 8,000 | $41.45 | Sell | $331,600.00 | |
Dec. 20, 2023 | Insider | 7,889 | $41.42 | Sell | $326,762.38 | |
Dec. 20, 2023 | CFO | 13,808 | $41.42 | Sell | $571,927.36 | |
Dec. 7, 2023 | Insider | 10,000 | $41.37 | Sell | $413,700.00 | |
Dec. 5, 2023 | Insider | 7,500 | $35.00 | Sell | $262,500.00 | |
Nov. 8, 2023 | Director | 100 | $25.16 | Sell | $2,516.00 | |
Nov. 3, 2023 | Director | 61,401 | $25.43 | Sell | $1,561,427.43 | |
Oct. 16, 2023 | Major Shareholder | 5,480,052 | $22.81 | Buy | $124,999,986.12 | |
Oct. 16, 2023 | Director | 876,808 | $22.81 | Buy | $19,999,990.48 | |
Sept. 7, 2023 | Director | 50,000 | $24.07 | Sell | $1,203,500.00 | |
Aug. 4, 2023 | Insider | 21,880 | $22.93 | Buy | $501,708.40 | |
Aug. 3, 2023 | CEO | 83,857 | $23.96 | Buy | $2,009,213.72 | |
July 11, 2023 | Director | 50,000 | $30.03 | Sell | $1,501,500.00 | |
June 15, 2023 | Director | 200,000 | $34.43 | Sell | $6,886,000.00 | |
June 2, 2023 | Insider | 1,895 | $32.95 | Sell | $62,440.25 | |
June 1, 2023 | CEO | 50,000 | $32.60 | Sell | $1,630,000.00 | |
May 4, 2023 | CEO | 50,000 | $31.47 | Sell | $1,573,500.00 | |
April 11, 2023 | CEO | 50,000 | $25.06 | Sell | $1,253,000.00 | |
March 3, 2023 | CEO | 3,000 | $27.19 | Sell | $81,570.00 | |
Feb. 7, 2023 | CEO | 50,000 | $33.13 | Sell | $1,656,500.00 | |
Jan. 5, 2023 | CEO | 50,000 | $29.94 | Sell | $1,497,000.00 | |
Dec. 9, 2022 | CEO | 50,000 | $26.67 | Sell | $1,333,500.00 | |
Oct. 4, 2022 | Insider | 25,000 | $30.00 | Sell | $750,000.00 | |
Sept. 12, 2022 | Director | 47,705 | $30.78 | Sell | $1,468,359.90 | |
Sept. 8, 2022 | President | 19,210 | $32.50 | Sell | $624,325.00 | |
Aug. 22, 2022 | President | 9,605 | $32.50 | Sell | $312,162.50 | |
Aug. 16, 2022 | Director | 1,425,000 | $35.00 | Buy | $49,875,000.00 | |
Aug. 10, 2022 | Insider | 55,000 | $40.50 | Sell | $2,227,500.00 | |
July 20, 2022 | Insider | 25,000 | $30.00 | Sell | $750,000.00 | |
July 5, 2022 | Insider | 25,000 | $30.00 | Sell | $750,000.00 | |
April 13, 2022 | Insider | 45,000 | $34.65 | Sell | $1,559,250.00 | |
March 29, 2022 | Insider | 10,000 | $35.00 | Sell | $350,000.00 | |
March 18, 2022 | Insider | 20,000 | $32.50 | Sell | $650,000.00 | |
March 16, 2022 | Insider | 25,000 | $30.00 | Sell | $750,000.00 | |
Feb. 9, 2022 | Insider | 25,000 | $30.00 | Sell | $750,000.00 | |
Dec. 27, 2021 | Insider | 4,127 | $35.00 | Sell | $144,445.00 | |
Dec. 23, 2021 | Insider | 5,873 | $35.00 | Sell | $205,555.00 | |
Dec. 21, 2021 | Insider | 7,300 | $32.50 | Sell | $237,250.00 | |
Dec. 17, 2021 | Insider | 7,122 | $32.50 | Sell | $231,465.00 | |
Dec. 15, 2021 | Insider | 25,000 | $30.02 | Sell | $750,500.00 | |
Nov. 10, 2021 | Insider | 55,000 | $39.86 | Sell | $2,192,300.00 | |
Aug. 25, 2021 | Director | 61,387 | $28.57 | Buy | $1,753,826.59 | |
Aug. 23, 2021 | Director | 44,437 | $25.78 | Buy | $1,145,585.86 |
Insiders are both buying and selling Cerevel Therapeutics Holdings Inc stock.
The insider traders at Cerevel Therapeutics Holdings Inc are: John Renger, N Anthony Coles, Perceptive Advisors Llc, Ambergate Trust, Abraham Ceesay, Mark Bodenrader, Scott Akamine, Marijn E Dekkers, Susan Altschuller, Deval L. Patrick, Paul D Burgess, Bain Capital Investors Llc, Ramiro Sanchez, Ronald C Renaud Jr, Gabrielle Sulzberger, and Kenneth Dipietro
The most active insider trader at Cerevel Therapeutics Holdings Inc is John Renger with 16 trades.
N Anthony Coles has sold the most Cerevel Therapeutics Holdings Inc stock with a total value of $21,670,612.67.
Bain Capital Investors Llc has bought the most Cerevel Therapeutics Holdings Inc stock with a total value of $249,999,972.24.
The most recent insider trade for Cerevel Therapeutics Holdings Inc was on July 1, 2024.
The single biggest insider buy for Cerevel Therapeutics Holdings Inc was from Bain Capital Investors Llc with a total value of $124,999,986.12 on Oct. 16, 2023.
The single biggest insider sell for Cerevel Therapeutics Holdings Inc was from Marijn E Dekkers with a total value of $6,886,000.00 on June 15, 2023.